Literature DB >> 8243853

Thrombogenic factors are related to urinary albumin excretion rate in type 1 (insulin-dependent) and type 2 (non-insulin-dependent) diabetic patients.

P Knöbl1, G Schernthaner, C Schnack, P Pietschmann, A Griesmacher, R Prager, M Müller.   

Abstract

Parameters of haemostasis, endothelial cell markers and lipid peroxide levels were studied in 64 Type 1 (insulin-dependent) and 94 Type 2 (non-insulin-dependent) diabetic patients according to their urinary albumin excretion rate in comparison with age-matched control subjects. We determined plasma levels of fibrinogen (Clauss' method), coagulation factor VII:activity (clotting assay), factor VII antigen, protein C and S antigen, von Willebrand factor antigen, D-dimer concentration (ELISA), and lipid peroxide levels (thiobarbituric acid) in relation to urinary albumin excretion rate (RIA). Significant positive correlations were found between urinary albumin excretion rate and plasma fibrinogen (p < 0.005, p < 0.02), factor VII activity (p < 0.0002, p < 0.002), factor VII antigen (p < 0.0001, p < 0.001), protein C (p < 0.003, p < 0.05), and lipid peroxides (p < 0.02, p < 0.004) in Type 1 as well as in Type 2 diabetes. Von Willebrand factor (p < 0.001) and protein S (p < 0.0005) correlated with albuminuria only in patients with Type 1 diabetes. Although most of the haemostatic abnormalities are already found in normoalbuminuric patients, the significant positive correlations to urinary albumin excretion indicate that endothelial cell damage and coagulation disorders deteriorate with the progression of diabetic nephropathy.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8243853     DOI: 10.1007/bf02374497

Source DB:  PubMed          Journal:  Diabetologia        ISSN: 0012-186X            Impact factor:   10.122


  33 in total

1.  Possible role for increased C4b-binding-protein level in acquired protein S deficiency in type I diabetes.

Authors:  A Ceriello; D Giugliano; A Quatraro; E Marchi; M Barbanti; P Lefebvre
Journal:  Diabetes       Date:  1990-04       Impact factor: 9.461

2.  Factor VII and extrinsic pathway inhibitor in acute coronary disease.

Authors:  P M Sandset; P A Sirnes; U Abildgaard
Journal:  Br J Haematol       Date:  1989-07       Impact factor: 6.998

3.  Microalbuminuria: a major risk factor in non-insulin-dependent diabetes. A 10-year follow-up study of 503 patients.

Authors:  A Schmitz; M Vaeth
Journal:  Diabet Med       Date:  1988-03       Impact factor: 4.359

4.  Haemostatic function and ischaemic heart disease: principal results of the Northwick Park Heart Study.

Authors:  T W Meade; S Mellows; M Brozovic; G J Miller; R R Chakrabarti; W R North; A P Haines; Y Stirling; J D Imeson; S G Thompson
Journal:  Lancet       Date:  1986-09-06       Impact factor: 79.321

5.  The levels of protein C and protein S in plasma in patients with type II diabetes mellitus.

Authors:  M Saito; I Kumabashiri; H Jokaji; H Asakura; C Uotani; M Otsuka; M Hamada; M Tatsumura; K Morinaga; T Matsuda
Journal:  Thromb Res       Date:  1988-12-01       Impact factor: 3.944

Review 6.  Lipid peroxidation in relation to prostacyclin and thromboxane physiology and pathophysiology.

Authors:  M A Warso; W E Lands
Journal:  Br Med Bull       Date:  1983-07       Impact factor: 4.291

7.  Effect of vitamin E supplementation on platelet thromboxane A2 production in type I diabetic patients. Double-blind crossover trial.

Authors:  C Gisinger; J Jeremy; P Speiser; D Mikhailidis; P Dandona; G Schernthaner
Journal:  Diabetes       Date:  1988-09       Impact factor: 9.461

8.  Features of endothelial dysfunction in early diabetic nephropathy.

Authors:  T Jensen; J Bjerre-Knudsen; B Feldt-Rasmussen; T Deckert
Journal:  Lancet       Date:  1989-03-04       Impact factor: 79.321

9.  Protein C antigen is not an acute phase reactant and is often high in ischemic heart disease and diabetes.

Authors:  S Viganò; P M Mannucci; A D'Angelo; C Gelfi; G F Gensini; C Rostagno; G G Neri Serneri
Journal:  Thromb Haemost       Date:  1984-12-29       Impact factor: 5.249

10.  Haemostatic variables associated with diabetes and its complications.

Authors:  J H Fuller; H Keen; R J Jarrett; T Omer; T W Meade; R Chakrabarti; W R North; Y Stirling
Journal:  Br Med J       Date:  1979-10-20
View more
  12 in total

1.  Impact of age, CYP2C9 genotype and concomitant medication on the rate of rise for prothrombin time during the first 30 days of warfarin therapy.

Authors:  Russell A Wilke; Richard L Berg; Humberto J Vidaillet; Michael D Caldwell; James K Burmester; Michael A Hillman
Journal:  Clin Med Res       Date:  2005-11

2.  Physiological inhibitors of blood coagulation and prothrombin fragment F 1 + 2 in type 2 diabetic patients with normoalbuminuria and incipient nephropathy.

Authors:  A Mormile; M Veglio; G Gruden; M Girotto; P Rossetto; P D'Este; P Cavallo-Perin
Journal:  Acta Diabetol       Date:  1996-09       Impact factor: 4.280

3.  Increased prothrombin fragment 1 + 2 and D-dimer in first-degree relatives of type 2 diabetic patients. Prethrombotic state in relatives of type 2 diabetic patients.

Authors:  M Fernández-Castañer; I Camps; J M Fernández-Real; P Domenech; F Martínez-Brotons
Journal:  Acta Diabetol       Date:  1996-07       Impact factor: 4.280

4.  Urinary albumin excretion is correlated to fibrinogen levels and protein S activity in patients with type 1 diabetes mellitus without overt diabetic nephropathy.

Authors:  Zoltán Lengyel; Péter Vörös; Lajos K Tóth; Csilla Németh; László Kammerer; Mária Mihály; László Tornóci; László Rosivall
Journal:  Wien Klin Wochenschr       Date:  2004-04-30       Impact factor: 1.704

5.  Association of D-dimer with microalbuminuria in patients with type 2 diabetes mellitus.

Authors:  Ichiro Wakabayashi; Hiroshi Masuda
Journal:  J Thromb Thrombolysis       Date:  2007-10-11       Impact factor: 2.300

Review 6.  The effects of GLP-1 analogues, DPP-4 inhibitors and SGLT2 inhibitors on the renal system.

Authors:  Guntram Schernthaner; Carl Erik Mogensen; Gerit-Holger Schernthaner
Journal:  Diab Vasc Dis Res       Date:  2014-09       Impact factor: 3.291

7.  A pharmacogenetics-based warfarin maintenance dosing algorithm from Northern Chinese patients.

Authors:  Jinxing Chen; Liying Shao; Ling Gong; Fang Luo; Jin'e Wang; Yi Shi; Yu Tan; Qianlong Chen; Yu Zhang; Rutai Hui; Yibo Wang
Journal:  PLoS One       Date:  2014-08-15       Impact factor: 3.240

8.  Effect of Aerobic Exercise Training on MDA and TNF- α Levels in Patients with Type 2 Diabetes Mellitus.

Authors:  Mihriban Arslan; Suleyman Hilmi Ipekci; Levent Kebapcilar; Nesrin Dogan Dede; Sevil Kurban; Ekrem Erbay; Mustafa Sait Gonen
Journal:  Int Sch Res Notices       Date:  2014-10-21

Review 9.  Proteinuria and its relation to cardiovascular disease.

Authors:  Gemma Currie; Christian Delles
Journal:  Int J Nephrol Renovasc Dis       Date:  2013-12-21

10.  Proteinuria independently predicts unfavorable outcome of ischemic stroke patients receiving intravenous thrombolysis.

Authors:  Chih-Hao Chen; Sung-Chun Tang; Li-Kai Tsai; Shin-Joe Yeh; Kai-Hsiang Chen; Chen-Hua Li; Yu-Jen Hsiao; Yu-Wei Chen; Bak-Sau Yip; Jiann-Shing Jeng
Journal:  PLoS One       Date:  2013-11-22       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.